Follow POL on Twitter - Tide turning against drug-pricing suits? Glaxo SmithKline beats back Kentucky case [Longstreth, AmLaw Daily]
- Court in Australia deems litigation funding pact improper as "unregistered managed investment scheme" [New Lawyer]
- Should docs be careful what they ask for? Michelle Mello of Harvard, a prominent advocate of health courts, hopes they'll significantly expand compensation [Gerencher, MarketWatch]
- Doubts about the latest phthalates scare, and a Daubert angle [Trevor Butterworth, Forbes]
- Claim: pay-to-play isn't such a big problem with public pension plaintiffs after all [Securities Litigation Watch, more]
- Chevron, trial lawyer adversaries locked in lobbying combat over Ecuador suit [Politico via Law & More]
